NASDAQ · IMMX
Immix Biopharma, Inc.
Healthcare · Biotechnology
$7.84
Down-$0.23 (-2.85%)
Updated Nov 14, 2026, 3:09 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 246.93M
- P/E ratio
- -9.97
- Dividend yield
- 0.00%
- 52-week range
- $7.12 – $15.10
- Volume
- 1.03M
- Avg. volume
- 730.89K
Price performance · IMMX
IMMX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
IMMX closed at $7.84 after 21 trading sessions, down 1.75% for the selected period.
- Last close
- $7.84
- Period change
- -1.75%
- Period low
- $7.20
- Period high
- $8.91
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $8.25 | $8.375 | $7.66 | $7.84 | 1.03M |
| Nov 12, 2026 | $8.40 | $8.50 | $8.06 | $8.07 | 960.3K |
| Nov 11, 2026 | $8.40 | $8.72 | $8.30 | $8.66 | 1.07M |
| Nov 10, 2026 | $8.37 | $8.77 | $8.1316 | $8.35 | 825.48K |
| Nov 9, 2026 | $8.09 | $8.89 | $7.90 | $8.57 | 1.27M |
| Nov 6, 2026 | $7.24 | $8.17 | $7.16 | $8.06 | 1.44M |
| Nov 5, 2026 | $7.86 | $7.95 | $7.12 | $7.20 | 1.41M |
| Nov 4, 2026 | $7.93 | $8.16 | $7.56 | $7.97 | 1.25M |
| Nov 3, 2026 | $7.33 | $7.80 | $7.1676 | $7.71 | 1.07M |
| Nov 2, 2026 | $7.65 | $7.9132 | $7.18 | $7.26 | 1.51M |
| Oct 30, 2026 | $7.86 | $8.10 | $7.56 | $7.68 | 1.38M |
| Oct 29, 2026 | $8.11 | $8.36 | $7.835 | $7.98 | 1.07M |
| Oct 28, 2026 | $7.98 | $8.21 | $7.88 | $8.125 | 1.24M |
| Oct 27, 2026 | $8.00 | $8.165 | $7.8486 | $8.05 | 1.15M |
| Oct 26, 2026 | $8.17 | $8.31 | $7.99 | $8.06 | 1.12M |
| Oct 23, 2026 | $8.34 | $8.89 | $7.88 | $8.15 | 1.2M |
| Oct 22, 2026 | $8.40 | $8.73 | $8.2301 | $8.35 | 817.97K |
| Oct 21, 2026 | $8.94 | $9.10 | $8.47 | $8.51 | 1.54M |
| Oct 20, 2026 | $8.26 | $9.03 | $8.235 | $8.91 | 1.23M |
| Oct 19, 2026 | $8.05 | $8.35 | $8.00 | $8.22 | 1.3M |
| Oct 16, 2026 | $8.67 | $8.67 | $7.95 | $7.98 | 1.5M |
Latest IMMX news
The latest Smart Investors Daily articles mentioning IMMX.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

